Vasoactive intestinal peptide (VIP): a new neuroendocrine marker of clinical progression in chronic heart failure?

MLA

Lucia, Piernatale, et al. “Vasoactive Intestinal Peptide (VIP): A New Neuroendocrine Marker of Clinical Progression in Chronic Heart Failure?” Clinical Endocrinology, vol. 59, no. 6, Dec. 2003, pp. 723–27. EBSCOhost, https://doi.org/10.1046/j.1365-2265.2003.01913.x.

APA

Lucia, P., Caiola, S., Coppola, A., Manetti, L. L., Maroccia, E., Buongiorno, A. M., & De Martinis, C. (2003). Vasoactive intestinal peptide (VIP): a new neuroendocrine marker of clinical progression in chronic heart failure? Clinical Endocrinology, 59(6), 723–727. https://doi.org/10.1046/j.1365-2265.2003.01913.x

Chicago

Lucia, Piernatale, Stefania Caiola, Alessandro Coppola, Luca L Manetti, Ettore Maroccia, Angela M Buongiorno, and Carlo De Martinis. 2003. “Vasoactive Intestinal Peptide (VIP): A New Neuroendocrine Marker of Clinical Progression in Chronic Heart Failure?” Clinical Endocrinology 59 (6): 723–27. doi:10.1046/j.1365-2265.2003.01913.x.